Veness Adam M: insider trades.
Veness Adam M reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($2.2M), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Veness Adam M
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | Officer · SVP, General Counsel and Sec. | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-13 | Dianthus Therapeutics, Inc. /DE/ | M | 15,000 | $18.17 | 15,000 | Form 4 |
| 2026-08-10 | Dianthus Therapeutics, Inc. /DE/ | M | 16,167 | $17.88 | 16,167 | Form 4 |
| 2026-08-10 | Dianthus Therapeutics, Inc. /DE/ | S | 16,167 | $110.38 | 0 | Form 4 |
| 2026-08-07 | Dianthus Therapeutics, Inc. /DE/ | S | 616 | $111.18 | 0 | Form 4 |
| 2026-08-07 | Dianthus Therapeutics, Inc. /DE/ | S | 3,217 | $110.61 | 616 | Form 4 |
| 2026-08-07 | Dianthus Therapeutics, Inc. /DE/ | M | 3,833 | $17.88 | 3,833 | Form 4 |
Questions
What stock did Veness Adam M buy or sell?
Veness Adam M reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($2.2M), across 1 company.
Is Veness Adam M the same person as other filers with this name?
This page covers SEC CIK 1778623 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/veness-adam-m-1778623.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.